Company

Neuprozyme Therapeutics Aps is a Danish biotech company founded in 2018 by LJP Holding Aps. The company builds on more than 25 years of research into the biochemistry, enzymology and crystal structure of Dipeptidyl Peptidase I (DPPI; also known as Cathepsin C) at Unizyme Laboratories AS –
a subsidiary of LJP Holding.

Board

Coming soon

Management

Coming soon